Fermentalg (FALG) Q4 2024 TU earnings summary

Executive summary

• Achieved record annual sales of €11.5 million in 2024, nearly tripling 2023 sales and surpassing the initial €10 million target.

• Growth driven by expansion into new market segments, notably infant nutrition (12% of sales) and animal nutrition (7%).

• Despite order cancellations and deferrals from two major customers, sales performance remained strong.

Financial highlights

• 2024 sales reached €11.5 million, up from €4 million in 2023.

• Sales target for 2024 was initially €10 million, later revised to €12 million.

• Sales cycles for new segments average 18 months.

Outlook and guidance

• Targeting at least €25 million in sales by 2026, confirming a profitable growth trajectory.

• 2025 action plan to focus on accelerating nutritional lipid sales, launching natural food colorants, and advancing R&D-driven growth drivers.

• Next financial results publication scheduled for March 20, 2025.